Literature DB >> 26277582

Programmed cell death-1 is expressed in large retinal ganglion cells and is upregulated after optic nerve crush.

Wei Wang1, Ann Chan2, Yu Qin2, Jacky M K Kwong2, Joseph Caprioli2, Ralph Levinson2, Ling Chen3, Lynn K Gordon4.   

Abstract

Programmed cell death-1 (PD-1) is a key negative receptor inducibly expressed on T cells, B cells and dendritic cells. It was discovered on T cells undergoing classical programmed cell death. Studies showed that PD-1 ligation promotes retinal ganglion cell (RGC) death during retinal development. The purpose of this present study is to characterize PD-1 regulation in the retina after optic nerve crush (ONC). C57BL/6 mice were subjected to ONC and RGC loss was monitored by immunolabelling with RNA-binding protein with multiple splicing (Rbpms). Time course of PD-1 mRNA expression was determined by real-time PCR. PD-1 expression was detected with anti-PD-1 antibody on whole mount retinas. PD-1 staining intensity was quantitated. Colocalization of PD-1 and cleaved-caspase-3 after ONC was analyzed. Real-time PCR results demonstrated that PD-1 gene expression was significantly upregulated at day 1, 3, 7, 10 and 14 after ONC. Immunofluorescent staining revealed a dramatic increase of PD-1 expression following ONC. In both control and injured retinas, PD-1 tended to be up-expressed in a subtype of RGCs, whose somata size were significantly larger than others. Compared to control, PD-1 intensity in large RGCs was increased by 82% in the injured retina. None of the large RGCs expressed cleaved-caspase-3 at day 5 after ONC. Our work presents the first evidence of PD-1 induction in RGCs after ONC. This observation supports further investigation into the role of PD-1 expression during RGC death or survival following injury. Published by Elsevier Ltd.

Entities:  

Keywords:  Apoptosis; Large retinal ganglion cells; Neuroprotection; Optic nerve crush; Programmed cell death-1

Mesh:

Substances:

Year:  2015        PMID: 26277582      PMCID: PMC5420326          DOI: 10.1016/j.exer.2015.08.008

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  34 in total

1.  Measurement of Domain-Specific HER2 (ERBB2) Expression May Classify Benefit From Trastuzumab in Breast Cancer.

Authors:  Daniel E Carvajal-Hausdorf; Kurt A Schalper; Lajos Pusztai; Amanda Psyrri; Konstantine T Kalogeras; Vasiliki Kotoula; George Fountzilas; David L Rimm
Journal:  J Natl Cancer Inst       Date:  2015-05-19       Impact factor: 13.506

2.  Glucocorticoid suppresses BDNF-stimulated MAPK/ERK pathway via inhibiting interaction of Shp2 with TrkB.

Authors:  Emi Kumamaru; Tadahiro Numakawa; Naoki Adachi; Hiroshi Kunugi
Journal:  FEBS Lett       Date:  2011-09-19       Impact factor: 4.124

3.  Quantitative analysis of retinal ganglion cell survival with Rbpms immunolabeling in animal models of optic neuropathies.

Authors:  Jacky M K Kwong; Ann Quan; Haksu Kyung; Natik Piri; Joseph Caprioli
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-12-28       Impact factor: 4.799

4.  Comparison of c-met expression in ovarian epithelial tumors and normal epithelia of the female reproductive tract by quantitative laser scan microscopy.

Authors:  D Huntsman; J H Resau; E Klineberg; N Auersperg
Journal:  Am J Pathol       Date:  1999-08       Impact factor: 4.307

5.  Form and function of the M4 cell, an intrinsically photosensitive retinal ganglion cell type contributing to geniculocortical vision.

Authors:  Maureen E Estevez; P Michelle Fogerson; Marissa C Ilardi; Bart G Borghuis; Eric Chan; Shijun Weng; Olivia N Auferkorte; Jonathan B Demb; David M Berson
Journal:  J Neurosci       Date:  2012-09-26       Impact factor: 6.167

6.  Role of p38 mitogen-activated protein kinase in axotomy-induced apoptosis of rat retinal ganglion cells.

Authors:  M Kikuchi; L Tenneti; S A Lipton
Journal:  J Neurosci       Date:  2000-07-01       Impact factor: 6.167

Review 7.  Molecular basis of glutamate toxicity in retinal ganglion cells.

Authors:  N J Sucher; S A Lipton; E B Dreyer
Journal:  Vision Res       Date:  1997-12       Impact factor: 1.886

Review 8.  The PD-1 pathway in tolerance and autoimmunity.

Authors:  Loise M Francisco; Peter T Sage; Arlene H Sharpe
Journal:  Immunol Rev       Date:  2010-07       Impact factor: 12.988

9.  Programmed cell death 1 forms negative costimulatory microclusters that directly inhibit T cell receptor signaling by recruiting phosphatase SHP2.

Authors:  Tadashi Yokosuka; Masako Takamatsu; Wakana Kobayashi-Imanishi; Akiko Hashimoto-Tane; Miyuki Azuma; Takashi Saito
Journal:  J Exp Med       Date:  2012-05-28       Impact factor: 14.307

10.  Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death.

Authors:  Y Ishida; Y Agata; K Shibahara; T Honjo
Journal:  EMBO J       Date:  1992-11       Impact factor: 11.598

View more
  7 in total

1.  Modulation of PDCD1 exon 3 splicing.

Authors:  Junjie Sun; Jialin Bai; Tao Jiang; Yuan Gao; Yimin Hua
Journal:  RNA Biol       Date:  2019-08-28       Impact factor: 4.652

2.  PD-1 is required to maintain stem cell properties in human dental pulp stem cells.

Authors:  Yao Liu; Huan Jing; Xiaoxing Kou; Chider Chen; Dawei Liu; Yan Jin; Li Lu; Songtao Shi
Journal:  Cell Death Differ       Date:  2018-02-22       Impact factor: 15.828

3.  Loss of Rbfox1 Does Not Affect Survival of Retinal Ganglion Cells Injured by Optic Nerve Crush.

Authors:  Lei Gu; Jacky M Kwong; Joseph Caprioli; Natik Piri
Journal:  Front Neurosci       Date:  2021-05-24       Impact factor: 4.677

Review 4.  Emerging Role of PD-1 in the Central Nervous System and Brain Diseases.

Authors:  Junli Zhao; Alexus Roberts; Zilong Wang; Justin Savage; Ru-Rong Ji
Journal:  Neurosci Bull       Date:  2021-04-20       Impact factor: 5.271

5.  Nogo receptor knockdown and ciliary neurotrophic factor attenuate diabetic retinopathy in streptozotocin-induced diabetic rats.

Authors:  Xiliang Guo; Xuezheng Liu
Journal:  Mol Med Rep       Date:  2017-06-23       Impact factor: 2.952

6.  A novel retinal ganglion cell quantification tool based on deep learning.

Authors:  Luca Masin; Marie Claes; Steven Bergmans; Lien Cools; Lien Andries; Benjamin M Davis; Lieve Moons; Lies De Groef
Journal:  Sci Rep       Date:  2021-01-12       Impact factor: 4.379

7.  In tumor cells, thyroid hormone analogues non-immunologically regulate PD-L1 and PD-1 accumulation that is anti-apoptotic.

Authors:  Hung-Yun Lin; Yu-Tang Chin; Ya-Jung Shih; Yi-Ru Chen; Matthew Leinung; Kelly A Keating; Shaker A Mousa; Paul J Davis
Journal:  Oncotarget       Date:  2018-09-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.